Kidney Cancer Playlist

Gain expert insights into treatment individualization in early-stage and metastatic RCC, as well as treatment sequencing, the role of novel endpoints, and the place of radiotherapy.

1. What are the characteristics that affect your decision to use dual I-O vs. I-O and a TKI? 
    Answered by Dr. Christian Kollmannsberger 

2. What is the role of the treatment-free interval in RCC?
    Answered by Dr. Christian Kollmannsberger 

3. In which patients is the use of adjuvant I-O indicated?
    Answered by Dr. Aly-Khan Lalani

4. How does the use of adjuvant I-O affect your use of I-O therapy in the metastatic setting?
    Answered by Dr. Aly-Khan Lalani

5. What is the role for RT in the treatment of RCC?
    Answered by Dr. Christian Kollmannsberger 

6. How does the presence of sarcomatoid features influence your treatment decisions in RCC?
    Answered by Dr. Aly-Khan Lalani

I-O: immuno-oncology - RCC: renal cell carcinoma - RT: radiotherapy - TKI: tyrosine kinase inhibitor